NO20091374L - Pyrrolotriazin kinase inhibitorer - Google Patents
Pyrrolotriazin kinase inhibitorerInfo
- Publication number
- NO20091374L NO20091374L NO20091374A NO20091374A NO20091374L NO 20091374 L NO20091374 L NO 20091374L NO 20091374 A NO20091374 A NO 20091374A NO 20091374 A NO20091374 A NO 20091374A NO 20091374 L NO20091374 L NO 20091374L
- Authority
- NO
- Norway
- Prior art keywords
- kinase inhibitors
- formula
- pyrrolotriazine kinase
- pyrrolotriazine
- compounds
- Prior art date
Links
- SUPXSFXAMJPEPH-UHFFFAOYSA-N 5h-pyrrolo[3,2-d]triazine Chemical compound N1=NC=C2NC=CC2=N1 SUPXSFXAMJPEPH-UHFFFAOYSA-N 0.000 title 1
- 229940043355 kinase inhibitor Drugs 0.000 title 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 101100335081 Mus musculus Flt3 gene Proteins 0.000 abstract 1
- 101150111783 NTRK1 gene Proteins 0.000 abstract 1
- 101150117329 NTRK3 gene Proteins 0.000 abstract 1
- 101150056950 Ntrk2 gene Proteins 0.000 abstract 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 abstract 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86417506P | 2006-11-03 | 2006-11-03 | |
| PCT/US2007/083436 WO2008057994A2 (en) | 2006-11-03 | 2007-11-02 | Pyrrolotriazine kinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20091374L true NO20091374L (no) | 2009-07-21 |
Family
ID=39365255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20091374A NO20091374L (no) | 2006-11-03 | 2009-04-03 | Pyrrolotriazin kinase inhibitorer |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7982033B2 (enExample) |
| EP (1) | EP2081936B1 (enExample) |
| JP (1) | JP5180967B2 (enExample) |
| CN (1) | CN101535312B (enExample) |
| NO (1) | NO20091374L (enExample) |
| WO (1) | WO2008057994A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2041138E (pt) | 2006-07-07 | 2014-10-07 | Bristol Myers Squibb Co | Inibidores de pirrolotriazina quinase |
| US8268998B2 (en) * | 2006-11-03 | 2012-09-18 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
| CN102105150B (zh) | 2008-05-21 | 2014-03-12 | 阿里亚德医药股份有限公司 | 用作激酶抑制剂的磷衍生物 |
| JP5592890B2 (ja) * | 2008-10-08 | 2014-09-17 | ブリストル−マイヤーズ スクイブ カンパニー | ピロロトリアジンキナーゼ阻害剤 |
| TW201035100A (en) | 2008-12-19 | 2010-10-01 | Cephalon Inc | Pyrrolotriazines as ALK and JAK2 inhibitors |
| JP5093527B2 (ja) * | 2010-02-10 | 2012-12-12 | 日本電気株式会社 | 複合光導波路、波長可変フィルタ、波長可変レーザ、および光集積回路 |
| CA2809331C (en) * | 2010-08-27 | 2018-09-25 | Merck Patent Gmbh | Triazolopyrazine derivatives |
| CN103848833B (zh) * | 2012-11-28 | 2016-08-31 | 上海希迈医药科技有限公司 | 吡咯并三嗪类衍生物、其制备方法及其在医药上的应用 |
| RU2650512C2 (ru) | 2013-09-18 | 2018-04-16 | Бейджин Ханми Фармасьютикал Ко., Лтд. | Соединение, ингибирующее активности киназ ВТК и/или JAK3 |
| CN104974163B (zh) * | 2014-04-14 | 2017-11-07 | 广东东阳光药业有限公司 | 取代的杂芳基化合物及其组合物和用途 |
| FR3025717A1 (fr) * | 2014-09-16 | 2016-03-18 | Univ Lille Sciences Tech | Utilisation conjointe d'un inhibiteur de trka et d'un inhibiteur de epha2 pour une utilisation dans le traitement de cancers |
| WO2016190847A1 (en) * | 2015-05-26 | 2016-12-01 | Calitor Sciences, Llc | Substituted heteroaryl compounds and methods of use |
| WO2017004134A1 (en) * | 2015-06-29 | 2017-01-05 | Nimbus Iris, Inc. | Irak inhibitors and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000071129A1 (en) | 1999-05-21 | 2000-11-30 | Bristol-Myers Squibb Company | Pyrrolotriazine inhibitors of kinases |
| US6982265B1 (en) | 1999-05-21 | 2006-01-03 | Bristol Myers Squibb Company | Pyrrolotriazine inhibitors of kinases |
| US6670357B2 (en) | 2000-11-17 | 2003-12-30 | Bristol-Myers Squibb Company | Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| EE200300227A (et) | 2000-11-17 | 2003-10-15 | Bristol-Myers Squibb Company | P38 kinaasiga seotud haigusseisundite ravimeetodid ja kinaasi inhibiitoritena kasulikud pürrolotriasiiniühendid |
| BR0309669A (pt) | 2002-04-23 | 2005-03-01 | Bristol Myers Squibb Co | Compostos de anilina de pirrolo-triazina úteis como inibidores de cinase |
| AU2003265349A1 (en) | 2002-08-02 | 2004-02-23 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
| CA2425123C (en) * | 2003-01-16 | 2010-09-21 | Decoma International Inc. | Lightweight composite tailgate |
| WO2008021859A1 (en) | 2006-08-09 | 2008-02-21 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
| US7531539B2 (en) | 2006-08-09 | 2009-05-12 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
| WO2008131050A1 (en) | 2007-04-18 | 2008-10-30 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
-
2007
- 2007-11-02 US US12/447,751 patent/US7982033B2/en active Active
- 2007-11-02 JP JP2009536401A patent/JP5180967B2/ja not_active Expired - Fee Related
- 2007-11-02 EP EP07844826.3A patent/EP2081936B1/en active Active
- 2007-11-02 WO PCT/US2007/083436 patent/WO2008057994A2/en not_active Ceased
- 2007-11-02 CN CN2007800405379A patent/CN101535312B/zh not_active Expired - Fee Related
-
2009
- 2009-04-03 NO NO20091374A patent/NO20091374L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20100081662A1 (en) | 2010-04-01 |
| CN101535312A (zh) | 2009-09-16 |
| WO2008057994A2 (en) | 2008-05-15 |
| JP5180967B2 (ja) | 2013-04-10 |
| JP2010509348A (ja) | 2010-03-25 |
| US7982033B2 (en) | 2011-07-19 |
| CN101535312B (zh) | 2013-04-24 |
| WO2008057994A3 (en) | 2008-09-12 |
| EP2081936B1 (en) | 2014-04-02 |
| EP2081936A2 (en) | 2009-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20091374L (no) | Pyrrolotriazin kinase inhibitorer | |
| NO20082023L (no) | Pyrrolotriazin kinaseinhibitorer | |
| NO20090025L (no) | Pyrrolotriazinkinaseinhibitorer | |
| MX2007001127A (es) | Moduladores de pirrolo-piridina cinasa. | |
| NO20062188L (no) | Pyrazolderivater som inhibitorer av reseptor tyrosin kinaser | |
| EA201100580A1 (ru) | Имидазопиридазинкарбонитрилы, используемые в качестве ингибиторов киназы | |
| WO2008060907A3 (en) | Pyrrolo-pyridine kinase inhibitors | |
| NO20081454L (no) | Met-kinaseinhibitorer | |
| ATE430747T1 (de) | 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren | |
| ATE469151T1 (de) | Pyrrolopyridinderivate als proteinkinaseinhibitoren | |
| NO20081893L (no) | 4-(3-aminopyrazol)pyrimidinderivater til anvendelse som tyrosin-kinaseinhibitorer i behandling av kreft | |
| NO20074275L (no) | 2- (4-okso-4H-kinazolin-3-yl) acetamider og deres anvendelse som Vasopressin-V3-antagonister | |
| DE602008005771D1 (de) | Disubstituierte alkyl-8-azabicycloä3.2.1üoktan-verbindungen als mu-opioid-rezeptorantagonisten | |
| MX2009006170A (es) | Compuestos y composiciones como inhibidores de cinasa. | |
| ATE527253T1 (de) | Pyrimidin-substituierte benzimidazolderivate als proteinkinasehemmer | |
| ECSP077994A (es) | Aminopirimidinas como moduladores de cinasa | |
| NO20082285L (no) | 3-aminosyklopentankarboksamider som modulatorer av kjemokinreseptorer | |
| ECSP077997A (es) | Moduladores de alquilquinolina y alquilquinazolina cinasa | |
| NO20092035L (no) | Tiazolylforbindelser anvendbare som kinaseinhibitorer | |
| NI200700316A (es) | Aminopirimidinas como moduladores de la cinasa | |
| EA200700365A1 (ru) | Производные индол-2-карбоксамидина как антагонисты nmda рецептора | |
| NO20080553L (no) | Azinyl-3-sulfonylindazolderivater som 5-hydroksytrypyamin-6 ligander | |
| NO20080937L (no) | Substituerte-3-sulfonylindazolderivater som 5-hydroksytryptamin-6-ligander | |
| MY139016A (en) | PYRAZOLOPYRIDINE DERIVATIVES AS INHIBITORS OF ß-ADRENERGIC RECEPTOR KINASE 1 | |
| NO20080160L (no) | Mellomprodukter nyttige i syntesene av alkylkinolin og alkylkinazolin kinasemodulatorer og beslektede fremgangsmater for synteser |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |